祁昌杰 柴立民 许明东 邝自珍 张宁.再生障碍性贫血中医药防治研究进展[J].现代生物医学进展英文版,2015,15(26):5174-5177. |
再生障碍性贫血中医药防治研究进展 |
The Research Progress on Preventive Treatment for Aplastic Anemia byTraditional Chinese Medicine |
|
DOI: |
中文关键词: 再生障碍性贫血 中医病因病机 免疫机制 中医药治疗 |
英文关键词: Aplastic anemia Etiology and pathogenesis of traditional Chinese medicine Immunologic mechanism Preventive treatment
of traditional Chinese medicine |
基金项目:国家自然科学基金项目(81373583) |
|
Hits: 819 |
Download times: 0 |
中文摘要: |
再生障碍性贫血是由多种原因引起的骨髓造血功能衰竭,以全血细胞减少为特征的一种综合病症。目前普遍认为其发病机
理与免疫因素介导的造血干细胞受损导致造血微环境异常相关。近年来,中医药以其独特的理论体系和治疗方法,在再生障碍性
贫血的病因病机及防治防等研究方面取得了较大进展。中医药防治再生障碍性贫血一般从肾精亏虚、毒损髓络、生血乏源入手,
以补肾填精、生血解毒为治疗法则,采用中药方剂或/ 和联合西药,可提高治疗有效率,降低西药的毒副作用,并可以调控T淋巴
细胞的分化及相关细胞因子的表达。中药治疗可以改善骨髓造血微环境、不同程度的恢复骨髓的造血功能,提高患者的生存质
量。现就中医药对此病的相关研究作一综述。 |
英文摘要: |
Aplastic Anemia (AA) is a syndrome caused by the reduction of whole blood cells and bone-marrow failure characterized
by peripheral pancytopenia and marrow hypoplasia. AA's pathogenesis is related to abnormal hematopoietic microenvironment induced
by damaging hematopoietic stemcells mediated by immunoreaction. The studies have received greater progress in etiology, pathogenesis
and preventive treatment for AA therapy by Traditional Chinese Medicine (TCM). The TCMtherapy for AA was based on deficiency
of the kidney essence, toxicity injures marrow meridian collaterals and production of the blood disorder. Its principle of treatment
was nourishing Kidney essence, nourishing the blood and detoxification. The treatment combined Chinese and western medicines can increase
the curative effect, decrease the toxic and side effects of western medicines, regulate the differentiation of T lymphocytes and the
expression of related cytokines. Chinese medicines could improve the bone marrow hematopoietic microenvironment and restore the
hematopoietic function for improving the survival quality of patients. This paper was a review for the studies of the research progress of
preventive treatment for AA by TCMin recent years. |
View Full Text
View/Add Comment Download reader |
Close |